Biologics: Targets and Therapy : Impact Factor & More
eISSN: 1177-5491pISSN: 1177-5475
Open AccessShare this on:
Key Metrics
CiteScore 
5.7
SJR
Q2Oncology
SNIP
1.05
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Biologics: Targets and Therapy Journal Specifications
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2390 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2007 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Biologics: Targets and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Biologics: Targets and Therapy
Enhancement of Gastric Mucosal Defense by Phytomedicine in the Context of H. pylori-Associated Ulcer Disease.
- 1 Apr 2026
- Biologics : targets & therapy
Rheumatoid Factor Beyond Rheumatoid Arthritis: A Potential Marker of Cardiometabolic and Hepatic Risk.
- 1 Apr 2026
- Biologics : targets & therapy
Anifrolumab in Refractory Oral Manifestations in Systemic Lupus Erythematosus: A Case Report and Literature Review
- 16 Mar 2026
- Biologics : Targets & Therapy
Late-Onset Ocular Myasthenia Gravis–Like Symptoms During Erenumab Therapy for Chronic Migraine: A Case Report
- 4 Mar 2026
- Biologics : Targets & Therapy
First-Line Serplulimab versus Other Anti-PD-1/PD-L1 Antibodies Plus Chemotherapy for Esophageal Squamous Cell Carcinoma: A Systematic Review with Benefit-Risk Assessment via Matching-Adjusted Indirect Comparison
- 1 Feb 2026
- Biologics: Targets and Therapy
Network Pharmacology-Based Exploration: Non-Targeted Metabolites of Lactobacillus-Fermented Chaenomeles speciosa (Sweet) Nakai, Smilax glabra Roxb. and Pueraria montana var. Lobata in Uric Acid Metabolism Intervention.
- 1 Feb 2026
- Biologics : targets & therapy
Enhancement of Gastric Mucosal Defense by Phytomedicine in the Context of H. pylori-Associated Ulcer Disease.
- 1 Apr 2026
- Biologics : targets & therapy
Rheumatoid Factor Beyond Rheumatoid Arthritis: A Potential Marker of Cardiometabolic and Hepatic Risk.
- 1 Apr 2026
- Biologics : targets & therapy
Anifrolumab in Refractory Oral Manifestations in Systemic Lupus Erythematosus: A Case Report and Literature Review
- 16 Mar 2026
- Biologics : Targets & Therapy
Late-Onset Ocular Myasthenia Gravis–Like Symptoms During Erenumab Therapy for Chronic Migraine: A Case Report
- 4 Mar 2026
- Biologics : Targets & Therapy
First-Line Serplulimab versus Other Anti-PD-1/PD-L1 Antibodies Plus Chemotherapy for Esophageal Squamous Cell Carcinoma: A Systematic Review with Benefit-Risk Assessment via Matching-Adjusted Indirect Comparison
- 1 Feb 2026
- Biologics: Targets and Therapy
Network Pharmacology-Based Exploration: Non-Targeted Metabolites of Lactobacillus-Fermented Chaenomeles speciosa (Sweet) Nakai, Smilax glabra Roxb. and Pueraria montana var. Lobata in Uric Acid Metabolism Intervention.
- 1 Feb 2026
- Biologics : targets & therapy
FAQs on Biologics: Targets and Therapy
How long has Biologics: Targets and Therapy been actively publishing? 
What is the publishing frequency of Biologics: Targets and Therapy?
How many articles did Biologics: Targets and Therapy publish last year?
What is the eISSN & pISSN for Biologics: Targets and Therapy?
What is Citescore for Biologics: Targets and Therapy?
What is SNIP score for Biologics: Targets and Therapy?
What is the SJR for Biologics: Targets and Therapy?
Who is the publisher of Biologics: Targets and Therapy?
